Cost-Effectiveness of Cetuximab, Cetuximab Plus Irinotecan, and Panitumumab for Third and Further Lines of Treatment for KRAS Wild-Type Patients with Metastatic Colorectal Cancer
| Autor: | Hoyle, Martin, Peters, Jaime, Crathorne, Louise, Jones-Hughes, Tracey, Cooper, Chris, Napier, Mark, Hyde, Chris |
|---|---|
| Zdroj: | In Value in Health March-April 2013 16(2):288-296 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect